More mRNA Vaccines for Low- and Lower-Middle-Income Countries Needed: Study

February 15, 2022

If a two-dose messenger RNA (mRNA)-based COVID-19 vaccine regimen were given to everyone in developing nations, 1.3 million deaths might be averted, a new study suggests.

And if a three-dose mRNA vaccine series were administered, 1.5 million COVID-19-related deaths could potentially be avoided, according to researchers from Yale, Stanford, Brown, the University of Maryland and the advocacy group Public Citizen.

To date, only 4 percent of the populations of low-income countries have received a full two-dose series, while 70 percent of the populations of high-income countries have received a full primary series, the researchers said.

View today's stories